zacks.com · 9 jul

Axon (AXON) Upgraded to Strong Buy: Here's What You Should Know

Axon (AXON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

zacks.com · 9 jul

Investors Heavily Search Axon Enterprise, Inc (AXON): Here is What You Need to Know

Axon (AXON) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

globenewswire.com · 8 jul

Federal Ruling Changes Economics of Nonlethal Law Enforcement

AUSTIN, Texas, July 08, 2026 (GLOBE NEWSWIRE) -- NetworkNewsWire Editorial Coverage : American law enforcement is in the middle of a legal and cultural reckoning over use of force. Courts are demanding more from officers before they reach for traditional weapons, and the Supreme Court's unanimous 2025 ruling in Barnes v.

zacks.com · 7 jul

Axon Enterprise (AXON) Advances While Market Declines: Some Information for Investors

Axon Enterprise (AXON) reached $640.46 at the closing of the latest trading day, reflecting a +2.91% change compared to its last close.

zacks.com · 7 jul

Is Axon Enterprise (AXON) Stock Outpacing Its Aerospace Peers This Year?

Here is how Axon Enterprise (AXON) and General Dynamics (GD) have performed compared to their sector so far this year.

247wallst.com · 6 jul

ITA Just Ripped Higher, but America’s Rearmament Cycle May Still Be in the First Inning

The iShares U.S. Aerospace and Defense ETF (BATS: ITA) has climbed 35% over the past year and nearly 17% year to date, and the reflexive retail question is whether the run is exhausted. The more useful question is whether ITA still fits the trade you actually want to make, which is long-cycle Western rearmament. Buying ITA... ITA Just Ripped Higher, but America's Rearmament Cycle May Still Be in the First Inning

investors.com · 6 jul

Axon Extends Win Streak On Target Hike, World Cup Drone Defense

The FAA granted a waiver for drone protection of World Cup stadiums.

zacks.com · 6 jul

Axon Crosses Its 200-Day SMA: Should You Buy the Stock Now?

AXON crosses its 200-day SMA as strong TASER, software and counter-drone demand support growth, despite an elevated valuation.